Education
Bachelor of Science in Pharmacology with 1st class honors, University Glasgow, Scotland. Doctor of Philosophy in Pharmacology, University Kansas.
Bachelor of Science in Pharmacology with 1st class honors, University Glasgow, Scotland. Doctor of Philosophy in Pharmacology, University Kansas.
Postdoctoral fellow Johns Hopkins University, Baltimore, 1975—1978. Associate professor Northwestern University Medical School, 1978—1983. With Nova Pharmaceuticals, 1983.
Executive vice president ICI/Zeneca, 1986—1997, international research director, 1994—1997. Chairman, president Research and development SmithKline Beecham Beecham, 1997—1999. Chief Executive Officer 3-Dimensional Pharmaceuticals, Inc., Yardley, Pennsylvania, 1999—2003, also board directors.
Chairman Oxagen Ltd., Oxford, Cyclacel Pharmaceuticals Inc., Berkeley Heights, New Jersey. Partner Red Abbey Venture Partners LP, Baltimore, Maryland, since 2004. President Druid Consulting LLC, since 2004.
Honorary professor University Glasgow. Instructor University Pennsylvania, Philadelphia. Board directors Lynx Therapuetics, Inc., Ocimum Biosolutions, Gaithersburg, Maryland, Naurex, Inc, Chicago.